Illimis Therapeutics
Biotechnology Research · 11 Employees
Phone Number: 82024456877
Email Address: mgt@illimistx.com
- Overview
- Employees
Access 14 Verified Employees Profiles for Illimis TherapeuticsUnlock Free Contacts Now
About
Illimis Therapeutics is a platform-based Korean biotech company developing a chimeric fusion protein platform for neurodegenerative diseases such as Alzheimer’s. Our platform is differentiated by its ability to address the concerns of antibody-induced neuroinflammation and subsequent ARIA (Amyloid-Related Imaging Abnormalities) often observed from existing antibody drugs that utilize FcR-mediated phagocytosis of microglia, by utilizing TAM receptor, a novel phagocytic receptor expressed on the surface of glial cells.
Website
Year Founded
2021
Social Media
LinkedinTwitter
Industry
Biotechnology Research
HQ Location
18, Heolleung-ro 569-gil, Gangnam-gu
Seoul, 06376, KR
Keywords
--
Location
- 18, Heolleung-ro 569-gil, Gangnam-gu Seoul, 06376, KR
Email Formats
Sign up for free credits and discover verified email addresses of Illimis Therapeutics
FormatExamples
first + last
andywarhol@illimistx.com
first_initial + last
awarhol@illimistx.com
first + last_initial
andyw@illimistx.com
first
andy@illimistx.com
last
warhol@illimistx.com
Frequently Asked Questions
Key Contacts
Similar Companies
Biotechnology Research
Get key business info for Illimis Therapeutics and other 100M companies. Start your seach.
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.